EXETF (Extendicare) Other Financing: $136 Mil (TTM As of Mar. 2026)


EXETF Extendicare Inc EXETF
76 GF Score
Price $24.85
GF Value $10.03
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Extendicare Other Financing?

Extendicare EXETF +0.49% 76 Other Financing is $136 Mil as of Mar. 2026. GuruFocus rates EXETF with a GF Score™ of 76/100 and a GF Value™ of $10.03 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Extendicare's Other Financing for the three months ended in Mar. 2026 was $-0 Mil.

Extendicare's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was $136 Mil.

Extendicare Other Financing Historical Data

* Premium members only.

The historical data trend for Extendicare's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Extendicare Other Financing Chart

Extendicare Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.45 -0.04 1.41 -2.32 -2.42

Extendicare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.12 -0.60 -0.14 137.27 -0.10
EXETF
76GF Score
Extendicare Inc EXETF
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Extendicare Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $136 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of $136 Mil mean?
Extendicare (EXETF) has a Other Financing of $136 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Extendicare and its competitors.
Is Extendicare's Other Financing too high?
Extendicare's current Other Financing is $136 Mil. Overall, Extendicare has a GF Score™ of 76/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Extendicare's Other Financing compare to HCA and THC?
Extendicare's Other Financing of $136 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Healthcare Providers & Services company?
A good Other Financing depends on the Healthcare Providers & Services industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Extendicare and its competitors. Extendicare's current Other Financing is $136 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Extendicare stock overvalued right now?
Based on GuruFocus' analysis, Extendicare (EXETF) is currently considered Significantly Overvalued. The stock's GF Value™ is $10.03, compared to a current price of $24.85 — trading 147.8% above its estimated fair value. The current Other Financing is $136 Mil. Extendicare's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Extendicare (EXETF), the current Other Financing is $136 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Extendicare (EXETF) Overvalued in 2026?

Based on GuruFocus' analysis, Extendicare stock appears to be overvalued. The current stock price of $24.85 is trading 147.8% above its estimated GF Value™ of $10.03. GuruFocus considers Extendicare to be Significantly Overvalued.

Key valuation signals for EXETF:

  • Other Financing: $136 Mil
  • GF Value™: $10.03 vs. price of $24.85 (147.8% above fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the EXETF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Extendicare Business Description

Address 3000 Steeles Avenue East, Suite 400, Markham, ON, CAN, L3R 4T9
Extendicare Inc is a senior care provider in Canada, focused on long-term care and home health care. The has three main business segments: Long-term Care (LTC), Home Health Care, and Managed Services. The Long-term Care segment, operating under the Extendicare brand, represents 53 owned homes in Ontario, Alberta and Manitoba. The Home Health Care segment, operating under the ParaMed brand, provides home health care services annually in Ontario, Alberta, Manitoba and Nova Scotia. The Managed Services segment, operating under the Extendicare Assist and SGP Purchasing Partner Network brands, provides management, consulting and group purchasing services to other care providers across Canada. The majority of the company's revenue is derived from the Long-term Care segment.
76GF Score

Get the complete analysis for EXETF

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$24.85
Price
$10.03
GF Value